Infection and stage | Duration | Transmission probability per act | Cofactor effects | Effects of HIV | Symptomatic (%)* | |||
---|---|---|---|---|---|---|---|---|
M→F | F→M | STI on HIV | Lack of circumcision on HIV/STI† | M | F | |||
Durations are the same for males and females unless otherwise noted. | ||||||||
F, female; HSV-2, herpes simplex virus 2; M, male; NA, not applicable. | ||||||||
*Proportion of symptomatic STIs are defined for treatable STIs including gonorrhoea, chlamydia, chancroid and syphilis. | ||||||||
†Pertains to increased acquisition uncircumcised compared with circumcised, males only. | ||||||||
‡For HSV-2, recurrent ulcers occur at an average frequency of 2.5 months for males and three months for females in the early latent stage. For the latent stage, ulcers recur less frequently, every six months on average for males and every eight months on average for females. | ||||||||
HIV | ||||||||
Primary | 10 weeks | 0.028 | 0.014 | 2 | None | |||
Asymptomatic | 5 years | 0.002 | 0.001 | 1 | None | |||
Symptomatic | 4 years | 0.006 | 0.003 | 1 | HSV-2 | |||
AIDS | 40 weeks | 0.014 | 0.007 | 1 | HSV-2 | |||
Chancroid | 11 weeks | 0.23 | 0.115 | 25 | 2 | 90 | 70 | |
Gonorrhoea | 14 weeks M, 14 weeks F | 0.26 | 0.13 | 3 | 1 | 45 | 14 | |
Chlamydia | 14 weeks M, 52 weeks F | 0.252 | 0.126 | 3 | 1 | 11 | 6 | |
Syphilis | ||||||||
Primary | 6 months | 0.175 | 0.088 | 7.5 | 2 | 50 | 20 | |
Early latent | 1 year | 0.018 | 0.009 | 1 | 1 | 0 | 0 | |
Latent | 2.5 years | 0 | 0 | 1 | 1 | 0 | 0 | |
Late latent | 12.5 years | 0 | 0 | 1 | 1 | 0 | 0 | |
HSV-2 | ||||||||
Primary | 3 weeks | 0.3 | 0.15 | 25 | 1 | |||
Early latent with recurrent ulcer‡ | 2 years | 0.01 | 0.005 | 1 | 1 | 4 | ||
Latent with recurrent ulcer‡ | 10 years | 0.005 | 0.003 | 1 | 1 | 4 | ||
Late latent | Lifelong | 0 | 0 | 1 | 1 | 4 | ||
Recurrent ulcer substage | 7 days | 0.2 | 0.1 | 10 | 1 | 4 | NA |